A new global research published in The Lancet journal has identified low back pain, depressive disorders, and headaches as the leading causes of poor health impacting overall quality of life. The study also examined how the COVID-19 pandemic has affected healthy life expectancy. The findings underscore the need for improved tools and access to treatment for these conditions.
-
Uncategorized
-
Uncategorized
A new cancer treatment has shown promise in reducing TB growth, particularly in drug-resistant bacteria. The medication, tested in unique cellular models, targets Mycobacterium tuberculosis, the bacteria that causes tuberculosis. It helps initiate natural cell death processes in infected cells. TB kills over 1.6 million people each year, and drug resistance is a growing concern. The researchers are hopeful that host-directed therapies, such as this one, can be a game-changer for infectious diseases. The therapy combines two inhibitors and can control TB growth up to 98%.
-
Uncategorized
The Maharashtra education department has included students with type-1 diabetes in the special needs category, allowing them to consume snacks and take medication in the classroom and during examinations. The decision was made based on the recommendations of the National Commission for Child Rights. Students using Continuous Glucose Monitoring, Flash Glucose Monitoring, and/or insulin pumps can have these devices with them during exams. Medication and provisions will also be made for students with type-1 diabetes during competitive and other examinations.
